国家/地区 中国（6）
IPC部 A（6）
IPC大类 A61（6）
IPC小类 A61K（6）
IPC A61K047/36（6）
发明人 QIN D（2） WANG L（2）
公开年 2014（3） 2021（2）
申请年 2021（3）  2014（2） 
专利权人 UNIV QILU TE.（2）

New dual-targeted amphiphillic glycan derivative carrier useful in medicinal composition for mild photothermal therapy of tumors, and for preparing antituheatingmor medicine for cancer tumors.

ZHOU X, ZHANG P, LIU N, HUO M

Preparing bovine serum albumin-graphene oxide modified chitosan nano drug-loading system comprises e.g. adding e.g. graphene oxide and chitosan, heating, carrying out reduced pressure distillation, dialyzing and freeze drying.

QIN D, WANG L

Preparing bovine serum albumin-nano-silver modified chitosan nano-drug-loading system, involves adding silver nitrate to solvent, adding nano-silver modified chitosan and folic acid modified bovine serum albumin conjugate, and freeze-drying.

QIN D, WANG L

Preparing hyaluronic acid/graphene oxide nanocomposite hydrogel used to control drug release comprises dissolving tyramine grafted hyaluronic acid in graphene oxide phosphate buffered saline solution, reacting with e.g. hydrogen peroxide.

CAO Z, LIAO L, SONG F

Nano super-molecule used for preparing camptothecin loaded nano super-molecule for treating cancer, comprises beta-cyclodextrin modified graphene and adamantane modified hyaluronic acid.

CAO Y, LIU Y, ZHANG Y

Preparation of graphene oxide derivative for oral colon-targeted hydrogel framework used for making oral nano-hydrogel colon cancer treating drug involves using aromatic azo compound or polysaccharide compound and graphene oxide.

JIANG G, ZHANG H, ZHANG Z, HOU L, FENG Q